<DOC>
	<DOCNO>NCT02616926</DOCNO>
	<brief_summary>Hepatocellular carcinoma ( HCC ) sixth common cancer world . For patient intermediate HCC ( BCLC stage B ) , transarterial chemoembolization ( TACE ) recommend standard therapy many clinical practice guideline . The combination TACE radiofrequency ablation ( RFA ) also report effective treatment . However , retrospective study report well therapeutic efficacy hepatic resection TACE intermediate HCC . The purpose study compare efficacy hepatic resection versus TACE+RFA treatment intermediate HCC prospective randomize clinical trial .</brief_summary>
	<brief_title>Hepatic Resection Versus TACE+RFA BCLC Stage B Hepatocellular Carcinoma</brief_title>
	<detailed_description>Barcelona Clinic Liver Cancer ( BCLC ) stag system widely use stage classification HCC management . For patient intermediate HCC , palliative treatment transarterial chemoembolization ( TACE ) recommend first choice treatment . However , recommendation remain controversial . The advice diagnosis treatment HCC former Chinese Ministry Health indicate BCLC may suitable China HCC patient find intermediate advanced stage . In recent year , study declare surgical resection well choice HCC patient BCLC stage B . However , lack randomization , small sample size lack prospective study limit strength evidence . To solve dilemma , prospective randomize control study perform compare efficacy ( 1- , 2- , 3-year survival ) surgical resection group TACE plus radiofrequency ablation group HCC patient intermediate stage . This study provide powerful evidence regard well treatment option HCC patient BCLC B stage , benefit treatment efficacy HCC patient BCLC B stage .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1 . Hepatocellular Carcinoma diagnose biopsy image criterion ( CT/MRI ) AFP 2 . Signed informed consent registration study 3 . ChildPugh class A B 4 . Eastern Cooperative Oncology Group Performance status 0 2 . 5 . BCLC stage B ( diameter single tumor ≥5cm number tumor ≥3 ) 6 . Hepatitis B history HBsAg positive 7 . Age 18 65 year 8 . No previous treatment 9 . Laboratory examination test : Platelet count ≥100×109/L ; ALT/AST ≤ 3 x ULN ; Cr1.5≤ x ULN ; INR &lt; 1.5 PT &lt; ULN +4s ; Alb≥30g/L ; Tbil≤34mmol/L 10 . For patient Hepatic resection group : radical surgery perform : ( 1 ) No segmental , lobar main portal vein bile duct thrombosis ; ( 2 ) lymph nodes metastasis ; ( 3 ) extra hepatic metastasis . 1. cachexia poor physical condition ; 2. pregnant HCG positive ; 3 . Portal vein bile duct thrombosis extra hepatic metastasis . 4 . Uncontrolled refractory ascites history hepatic encephalopathy 5 . Severe heart , brain kidney diseases 6. hemophilia patient coumarin derivative therapy . 7 . .history organ transplantation mental disease . 8 . Be allergic adriamycin , lobaplatin , mitomycin iodize oil</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>hepatocellular carcinoma</keyword>
	<keyword>hepatectomy</keyword>
	<keyword>transarterial chemoembolization</keyword>
	<keyword>radiofrequency ablation</keyword>
</DOC>